CLINICAL_TRIALS
trial_result
· 2023-11-18
Clinical Trial Update: A Study to Provide a Better Understanding of Baraclude's Pharmacokinetic Properties in a Real World Clinical Setting [Phase 1]
Summary
Phase 1 pharmacokinetic study of Baraclude (entecavir) in real-world setting to understand PK properties in hepatitis B patients.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis B Virus | Phase 1 | Status: COMPLETED | Results posted: 2023-11-18